MAPT H1 HAPLOTYPE IS A RISK FACTOR FOR ESSENTIAL TREMOR AND MULTIPLE SYSTEM ATROPHY

C VILARINO-GÜELL; A. I SOTO-ORTOLAZA; M. J FARRER; O. A ROSS; A RAJPUT; D. C MASH; S PAPAPETROPOULOS; R PAHWA; K. E LYONS; R. J UITTI; Z. K WSZOLEK; D. W DICKSON

doi:10.1212/WNL.0b013e31820c30c1

Back

MAPT H1 HAPLOTYPE IS A RISK FACTOR FOR ESSENTIAL TREMOR AND MULTIPLE SYSTEM ATROPHY

Journal article

Open access

Peer reviewed

MAPT H1 HAPLOTYPE IS A RISK FACTOR FOR ESSENTIAL TREMOR AND MULTIPLE SYSTEM ATROPHY

C VILARINO-GÜELL, A. I SOTO-ORTOLAZA, M. J FARRER, O. A ROSS, A RAJPUT, D. C MASH, S PAPAPETROPOULOS, R PAHWA, K. E LYONS, R. J UITTI, …

Neurology, Vol.76(7), pp.670-672

2011

DOI: https://doi.org/10.1212/WNL.0b013e31820c30c1

PMCID: PMC3053340

PMID: 21321341

Abstract

Neurology

Biological and medical sciences

Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis

Medical sciences

Files and links (1)

url

https://doi.org/10.1212/WNL.0b013e31820c30c1View

Published (Version of record) Open

Metrics

8 Record Views

61 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.52 Neurodegenerative Diseases; 1.52.67 Parkinson's Disease
Web Of Science research areas: Clinical Neurology
ESI research areas: Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: MAPT H1 HAPLOTYPE IS A RISK FACTOR FOR ESSENTIAL TREMOR AND MULTIPLE SYSTEM ATROPHY
Creators: C VILARINO-GÜELL - Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, United States
A. I SOTO-ORTOLAZA - Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, United States
M. J FARRER - Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, United States
O. A ROSS - Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, United States
A RAJPUT - Division of Neurology, Royal University Hospital, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
D. C MASH - Department of Neurology , School of Medicine, University of Miami, Miami, FL, United States
S PAPAPETROPOULOS - Department of Neurology , School of Medicine, University of Miami, Miami, FL, United States
R PAHWA - Department of Neurology , University of Kansas Medical Center, Kansas City, United States
K. E LYONS - Department of Neurology , University of Kansas Medical Center, Kansas City, United States
R. J UITTI - Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, FL, United States
Z. K WSZOLEK - Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, FL, United States
D. W DICKSON - Division of Neuropathology, Mayo Clinic College of Medicine, Jacksonville, FL, United States
Publication Details: Neurology, Vol.76(7), pp.670-672
Publisher: Lippincott Williams & Wilkins; Hagerstown, MD
Academic Unit: UMMG Department of Neurology
Language: English
Resource Type: Journal article
PMID: 21321341
PMCID: PMC3053340
Record Identifier: 991031575963502976